Belgian-French startup neuroClues has presented an innovative eye movement capture technology. With its help, the company intends to improve the diagnosis of neurodegenerative diseases.The principle of the headset is simple: the patient watches the movement of black dots in the device, and the AI evaluates the speed of reaction and the number of errors. The results obtained are interpreted by the doctor. According to the developers of neuroClue, eye movements can prevent the onset of Alzheimer’s, stroke and multiple sclerosis.The uniqueness of the gadget is that it can capture up to 800 simultaneous eye movements per second. So far, this is a record. In addition, it is portable and requires no additional equipment.hashtagThe startup has already filed an application with the FDA to use the technology. The company’s founders plan to get approval in 2026-27, and by 2032 neuroClue intends to help 10 million patients.